You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Spotlight on Skin of Color in Dermatology

  • Authors: Oma N. Agbai, MD, FAAD; Andrew F. Alexis, MD, MPH; Valerie D. Callender, MD, FAAD; Seemal R. Desai, MD, FAAD; Nada Elbuluk, MD, MSc, FAAD; Susan C. Taylor, MD
  • CME / ABIM MOC / CE Released: 5/19/2022
  • Valid for credit through: 5/19/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.50 ABIM MOC points

    Nurses - 1.50 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for dermatologists, primary care physicians (PCPs), pediatricians, nurses, nurse practitioners (NPs), and physician assistants (PAs) involved in the care of patients with dermatologic conditions.

The goal of this activity is to improve the management of dermatologic conditions in patients with skin of color.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Treatment strategies for managing psoriasis across a diverse array of patients
    • Individualizing acne treatments based on severity and patient characteristics (age, gender, Fitzpatrick skin type)
    • Development of individualized skin and haircare regimens for patients of different Fitzpatrick skin types
  • Have greater competence related to
    • Selecting atopic dermatitis (AD) treatments that consider patient-related factors such as age, severity, Fitzpatrick skin type, and comorbid conditions
    • Recommending over-the-counter (OTC) skincare that is most advantageous for dermatologic conditions in patients with skin of color


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Oma N. Agbai, MD, FAAD

    Director of Multicultural Dermatology and Hair Loss Disorders
    Assistant Clinical Professor of Dermatology
    University of California
    Davis School of Medicine
    Sacramento, California

    Disclosures

    Disclosure: Oma N. Agbai, MD, FAAD, has the following relevant financial relationships:
    Consultant or advisor for: Unilever; VisualDx
    Speaker or member of speakers bureau for: AbbVie

  • Andrew F. Alexis, MD, MPH

    Professor of Clinical Dermatology
    Weill Cornell Medicine
    New York, New York

    Disclosures

    Disclosure: Andrew F. Alexis, MD, MPH, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Allergan; Almirall; Amgen; Arcutis; Bausch Health; Beiersdorf; Bristol Myers Squibb; Dermavant; Eli Lilly; Galderma; Janssen; LEO Pharma, Inc.; L'Oreal; Pfizer; Sanofi-Regeneron; SolGel; UCB; Valeant; VisualDx; Vyne
    Speaker or member of speakers bureau for: Bristol Myers Squibb; Pfizer; Regeneron; Sanofi-Genzyme
    Research funding from: Almirall; Amgen; Arcutis; Bristol Myers Squibb; Cara; Dermavant; Galderma; LEO Pharma, Inc.; Menlo; Novartis; Valeant (Bausch Health)

  • Valerie D. Callender, MD, FAAD

    Professor of Dermatology
    Howard University College of Medicine
    Washington DC
    Medical Director
    Callender Dermatology & Cosmetic Center
    Glenn Dale, Maryland

    Disclosures

    Disclosure: Valerie D. Callender, MD, FAAD, has the following relevant financial relationships:
    Consultant or advisor for: Acne Store; Aerolase; Allergan/AbbVie; Avita; Beiersdorf; Cutera; Dermavant; Endo Aesthetics; EPI Health; Galderma; Incyte; Lilly; L'Oreal; Nutraceutical Wellness; Ortho Derm; Scientis; Sente; SkinCeutical
    Speaker or member of speakers bureau for: Incyte
    Research funding from: Allergan/AbbVie; Galderma; Lilly; L'Oreal; SkinBetter Science
    Stock options from: Aerolase
    Employed by an ineligible company: Callender Dermatology & Cosmetic Center

  • Seemal R. Desai, MD, FAAD

    Founder & Medical Director
    Innovative Dermatology
    Clinical Assistant Professor
    Department of Dermatology
    University of Texas Southwestern Medical Center
    Dallas, Texas

    Disclosures

    Disclosure: Seemal R. Desai, MD, FAAD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Almirall; Avita; Beiersdorf, Inc; Bristol Myers Squibb; Eli Lilly and Company; EPI Health; Ferndale Laboratories, Inc.; Galderma Laboratories, LP; Johnson and Johnson; Incyte Corporation; LEO Pharma Inc.; L'Oreal USA Inc; Ortho Dermatologics; Pfizer Inc.; Scientis; UCB; Verrica Pharmaceuticals, Inc
    Speaker or member of speakers bureau for: Dermavant Sciences; Galderma Laboratories, LP; Pfizer Inc.
    Research funding from: AbbVie; AOBiome, LLC; Dermavant Sciences; Incyte Corporation

  • Nada Elbuluk, MD, MSc, FAAD

    Clinical Associate Professor of Dermatology
    Keck School of Medicine of
    University of Southern California
    Los Angeles, California

    Disclosures

    Disclosure: Nada Elbuluk, MD, MSc, FAAD, has the following relevant financial relationships:
    Consultant or advisor for: Allergan; Avita; Galderma; Incyte; Janssen; Scientis; VisualDX; Zosano
    Speaker or member of speakers bureau for: Clinique; La Roche-Posay; Unilever
    Research funding from: Avita

  • Susan C. Taylor, MD

    Bernett L. Johnson Jr, MD Endowed Professor in Dermatology
    Perelman School of Medicine
    University of Pennsylvania
    Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Susan C. Taylor, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Amgen; Arcutis Biotherapeutics; Armis Scientific; Beiersdorf; Biorez; Evolus; Galderma; GloGetter; Jugel America; Janssen; Johnson & Johnson; L'Oreal USA; Piction Health; Senty Labs; Scientis US; UCB; Vichy Laboratories
    Speaker or member of speakers bureau for: Beiersdorf; Evolus; LivDerm; L'Oreal USA
    Research funding from: Arcutis; Concert Pharmaceuticals; Croma Pharma; Eli Lilly; Pfizer
    Stock options from: GloGetter; Piction Health
    Owns stock (privately owned) in: Biorez
    Monetary compensation for an executive role from: CannTec

Editors

  • Meghan Coulehan, MPH

    Senior Director, Content Development, Medscape, LLC

    Disclosures

    Disclosure: Meghan Coulehan, MPH, has no relevant financial relationships.

  • Briana Betz, PhD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Briana Betz, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Esther Nyarko, PharmD

    Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has no relevant financial relationships.

Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Spotlight on Skin of Color in Dermatology

Authors: Oma N. Agbai, MD, FAAD; Andrew F. Alexis, MD, MPH; Valerie D. Callender, MD, FAAD; Seemal R. Desai, MD, FAAD; Nada Elbuluk, MD, MSc, FAAD; Susan C. Taylor, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 5/19/2022

Valid for credit through: 5/19/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Highlighting Disparities in Diagnosis and Treatment of Atopic Dermatitis, Seborrheic Dermatitis, Psoriasis, and Acne in Skin of Color Patients

Can you identify the clinical differences in the phenotypic expression of dermatologic conditions?
Susan C. Taylor, MD, FAAD

The Acne and Rosacea Skin of Color Challenge

Do you have the tools to accurately assess and treat acne and rosacea?
Nada Elbuluk, MD, MSc, FAAD

Psoriasis in Skin of Color

The psychosocial impact of psoriasis in populations with skin of color is significant. Are you up to date on identifying psoriasis in your patients?
Andrew F. Alexis, MD, MPH

Atopic Dermatitis in Skin of Color

Atopic dermatitis has many morphologic manifestations. Are you up to date on recognizing AD?
Seemal R. Desai, MD, FAAD

Skin and Haircare Concerns in Patients of Color

Sharpen your skills on managing hyperpigmentation, hair breakage, traction alopecia, CCCA, frontal fibrosing alopecia, and acne.
Valerie D. Callender, MD, FAAD

Aesthetic Procedures in People of Color

Update your toolbox with unique approaches to evaluating patients of color presenting for cosmetic procedures.
Oma N. Agbai, MD, FAAD
 

Educational Impact Challenge

The goal of this activity is to improve the management of dermatologic conditions in patients with skin of color.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print